Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin J Oncol Nurs. 2007 Apr;11(2):237-41.

Pharmacologic application of sunitinib malate in the management of gastrointestinal stromal tumors.

Author information

  • Sylvester Comprehensive Cancer Center, Leonard M. Miller School of Medicine, University of Miami, Florida, USA. jmacintyre@med.miami.edu

Abstract

A gastrointestinal stromal tumor (GIST) is a soft tissue sarcoma that can occur anywhere along the gastrointestinal (GI) tract and is the most common noncarcinomatous malignancy of the GI tract. This article will review the pathology of GISTs, the molecular pathology related to c-kit, and disease management and will discuss a new drug approved in the management of GISTs, sunitinib malate. In addition, pharmacologic properties along with nursing considerations related to sunitinib malate will be reviewed.

PMID:
17573273
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for MetaPress.com
    Loading ...
    Write to the Help Desk